High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort

Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?

(2015) Miguel F. Carrascosa et al.   JOURNAL OF HEPATOLOGY

Mass treatment with statins

(2014) B. Goldacre et al.   BMJ-British Medical Journal

Non-cardiovascular effects associated with statins

(2014) C. S. Desai et al.   BMJ-British Medical Journal

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance

(2014) S. Rabar et al.   BMJ-British Medical Journal

Statins and The BMJ

(2014) F. Godlee   BMJ-British Medical Journal

Drug-Induced Autoimmune-Like Hepatitis

(2011) Albert J. Czaja   DIGESTIVE DISEASES AND SCIENCES

Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing

(2011) Einar Björnsson et al.   JOURNAL OF HEPATOLOGY

Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study

(2010) Adrian Reuben et al.   HEPATOLOGY

Drug-Induced Liver Injury Associated with Statins

(2009) Mark Russo et al.   SEMINARS IN LIVER DISEASE

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY